Organism
|
Receptors
|
Main cellular tropism
|
Proposed latency cell
|
Other tropism
|
References
|
---|
EBV
|
CD21, MHC-II, α5β1 integrin
|
B
|
B
|
EPC, EC
|
[8]
|
CMV
|
EGFR
|
M/M
|
M/M; EC
|
N, EPC, EC
|
[174]
|
HHV6
|
CD46+
|
M/M, T, B
|
M/M
|
N, EPC
|
[175]
|
HHV7
|
CD4+ heparan sulfate receptor
|
T
|
M/M
|
N, EPC, EC
|
[176,177]
|
HHV8
|
Heparan sulfate receptor, EGFR
|
EC, M/M, B, T
|
B
|
N, EPC
|
[174,178]
|
Chlamydia pneumoniae
|
Heparan sulfate receptor
|
M/M
| |
EC, EPC
|
[179]
|
Chlamydia trachomatis
| |
M/M
| |
EC, EPC
| |
Parvovirus B19
|
Erythrocyte P antigen
|
Erythroid precursors
| |
EC
|
[66,67]
|
- B, B cells; CMV, cytomegalovirus; EBV, Epstein–Barr virus; EC, endothelial cells; EGFR, epidermal growth factor receptor; EPC, epithelial cells; HHV, human herpesvirus; MHC, major histocompatibility complex; M/M, myelomonocytic cells; N, neural cells; T, T cells.